ArticleScientific reports2026
Data-driven explainable chronic kidney disease detection using RF based data imputation and meta-ensemble learning.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Data-driven explainable chronic kidney disease detection using RF based data imputation and meta-ensemble learning.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic kidney disease (CKD) is a progressive medical condition with significant public health impact, where early detection is critical for effective intervention. This work presents a clearly defined and structured data-driven framework designed to improve CKD prediction through robust preprocessing and optimized ensemble learning. This study proposes a novel hybrid framework that combines Random Forest (RF)-based imputation for missing value handling, categorical feature encoding, and synthetic minority oversampling technique (SMOTE) for addressing class imbalance, integrated with a Grey wolf optimizer (GWO)-based weighted ensemble of top-performing classifiers (Decision Tree, Logistic Regression, and Gaussian Naïve Bayes). The ensemble weights are optimized using the Grey Wolf optimizer (GWO) to enhance predictive accuracy. We evaluate the proposed framework on the UCI CKD dataset, demonstrating that it outperforms individual classifiers and conventional ensemble methods, achieving an accuracy of 98.75%, precision of 98.8%, recall of 98.6%, and F1-score of 98.7%. Additionally, explainable AI (XAI) techniques including SHAP and LIME are employed to analyze feature contributions, providing interpretable insights and confirming the clinical relevance of the predictions. Overall, the proposed framework offers a transparent, reliable, and computationally efficient clinical decision support model that bridges the gap between data-driven AI and nephrology practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.